ABEV AMBEV S.A. IFRS Annual reports only
Beverages · NYSE · SEC CIK 1565025 · Reporting currency BRL · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 · BRL | FY20242024-12-31 · BRL | FY20232023-12-31 · BRL | FY20222022-12-31 · BRL | FY20212021-12-31 · BRL |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 88.24B | 89.45B | 79.74B | 79.71B | 72.85B |
| Cost of revenue | 42.86B | 43.62B | 39.29B | 40.42B | 35.66B |
| Gross profit | 45.38B | 45.84B | 40.45B | 39.29B | 37.19B |
| SG&A expense | 5.86B | 6.20B | 5.27B | 5.24B | 4.88B |
| Operating income | 23.32B | 21.80B | 18.83B | 17.69B | 17.08B |
| Interest expense | 4.41B | 4.03B | 4.92B | 7.14B | 1.43B |
| Pretax income | 19.42B | 19.49B | 15.04B | 14.24B | 13.76B |
| Income tax | — | — | -75.50M | 655.60M | -636.60M |
| Net income | 15.50B | 14.44B | 14.50B | 14.46B | 12.67B |
| EPS (basic) | 0.99 | 0.92 | 0.92 | 0.92 | 0.81 |
| EPS (diluted) | 0.99 | 0.91 | 0.92 | 0.91 | 0.80 |
| Weighted avg. shares (diluted) | 15.68B | 15.81B | 15.84B | 15.85B | 15.86B |
| Balance sheet | |||||
| Cash & equivalents | 18.64B | 28.60B | 16.06B | 14.93B | 16.63B |
| Short-term investments | 1.68B | 1.24B | 277.20M | 454.50M | 1.91B |
| Receivables | 6.35B | 6.27B | 5.74B | 5.35B | 4.79B |
| Inventory | 10.52B | 11.69B | 9.62B | 12.92B | 11.00B |
| Current assets | 43.88B | 54.16B | 36.56B | 37.82B | 38.63B |
| PP&E, netmay include right-of-use assets (IFRS) | 27.64B | 30.17B | 26.63B | 30.06B | 29.22B |
| Goodwill | 41.54B | 44.34B | 38.00B | 40.59B | 42.41B |
| Intangibles | 11.04B | 12.53B | 10.04B | 9.22B | 8.69B |
| Total assets | 145.09B | 162.51B | 132.64B | 137.96B | 138.60B |
| Current liabilities | 45.60B | 49.39B | 41.01B | 40.54B | 38.87B |
| Short-term debt | 1.17B | 1.28B | 1.30B | 982.60M | 847.10M |
| Long-term debt | 2.22B | 2.18B | 2.20B | 2.79B | 2.25B |
| Total debt | 3.39B | 3.45B | 3.50B | 3.77B | 3.10B |
| Total liabilities | 56.31B | 62.93B | 52.50B | 54.63B | 54.58B |
| Shareholders' equity | 87.91B | 98.64B | 78.97B | 81.96B | 82.64B |
| Net debt | -15.25B | -25.14B | -12.56B | -11.16B | -13.53B |
| Shares outstanding | 15.76B | 15.76B | 15.75B | 15.75B | 15.74B |
| Cash flow statement | |||||
| Operating cash flow | 24.45B | 26.10B | 24.71B | 20.64B | 22.90B |
| Capital expenditure | 4.59B | 4.75B | 6.00B | 6.53B | 7.68B |
| Free cash flow | 19.86B | 21.35B | 18.71B | 14.11B | 15.22B |
| Investing cash flow | -4.95B | -5.46B | -5.77B | -5.00B | -7.74B |
| Financing cash flow | -26.77B | -10.35B | -16.12B | -16.34B | -16.04B |
| Stock-based compensation | 454.20M | 400.90M | 331.60M | 313.90M | 387.60M |
| Dividends paid | — | — | 543.90M | 357.40M | 2.65B |
| Share buybacks | — | 1.72B | — | 100,000 | 0 |
Free plan shows the latest 5 periods; Pro shows all 11 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· This company uses different currencies across periods or line items (e.g. USD convenience translations in annual reports). Each column header shows its currency and cells in a different currency are marked; do not compare figures across currencies. Charts use only periods in the latest period's currency.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.